MSc Biochemistry, University of Bern
Head Manufacturing; InnoMedica Switzerland
Pascal Halbherr, Head Manufacturing, joined InnoMedica in the fall of 2012. His interest in current research in biochemistry and his willingness to engage with novel concepts led to the launch of the collaboration with Dr. Yamazaki and formed the starting point of the project for the cancer drug. Together with Stéphane Gumy, he set up a GMP production facility at the Marly Innovation Center and adapted the production processes from research to an industrial scale.
Pascal Halbherr completed his bachelor's degree in biochemistry and his master's degree in immunology at the University of Bern (“Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions”).
